Division of Infectious Diseases, Department of Medicine, New York University School of Medicine, New York, NY, 10016.
J Addict Med. 2009 Sep;3(3):172-7. doi: 10.1097/ADM.0b013e31819eac4c.
Persons who use illicit drugs are at increased risk of new tuberculosis (TB) infection. We conducted a prospective cohort study to assess rates and risk factors for tuberculin skin test (TST) conversion among persons with a history of illicit drug use, who were enrolled in a methadone program and had a negative baseline 2-step TST (eligible participants).
TST and standardized interviews were administered to 401 eligible participants from 1995 through 1999, every 6 months for a 2-year follow-up time. Analyses were conducted in 2006.
A total of 1,447 repeat TSTs were performed during 843 person-years of follow-up (median: 2.0 years). The TST conversion rate was 3.7 per 100 person-years. In multivariate analysis, participants who converted were more likely to report ever having been homeless (HR, 2.4; 95% CI, 1.2-5.0) or ever having lived in a homeless shelter (HR, 2.4; 95% CI, 1.2-4.9) at the baseline interview, and less likely to have reported receiving public assistance since the last study visit (RR, 0.15; 95% CI, 0.07-0.32).
This is the first study utilizing 2-step TST at baseline to measure the incidence of TST conversion among persons who use illicit drugs. Controlling for homelessness, persons with a lack of current public assistance was identified as a risk factor for TST conversion. These individuals may most benefit from annual tuberculin skin testing.
使用非法药物的人感染新结核(TB)的风险增加。我们进行了一项前瞻性队列研究,以评估有非法药物使用史、参加美沙酮计划且基线 2 步 TST 阴性的人群中结核菌素皮肤试验(TST)转化的发生率和危险因素(合格参与者)。
1995 年至 1999 年期间,对 401 名合格参与者进行了 TST 和标准化访谈,随访时间为 2 年,每 6 个月进行一次。分析于 2006 年进行。
在 843 人年的随访期间共进行了 1447 次重复 TST(中位数:2.0 年)。TST 转化率为 3.7/100 人年。多变量分析显示,转化组参与者更有可能报告在基线访谈时曾无家可归(HR,2.4;95%CI,1.2-5.0)或曾居住在无家可归者收容所(HR,2.4;95%CI,1.2-4.9),并且更不可能报告自上次研究访问以来收到公共援助(RR,0.15;95%CI,0.07-0.32)。
这是第一项使用基线 2 步 TST 测量使用非法药物者 TST 转化发生率的研究。控制无家可归因素后,当前缺乏公共援助被确定为 TST 转化的危险因素。这些人可能最受益于每年进行结核菌素皮肤测试。